SANTA ANA, Calif.--Advanced Medical
Optics (NYSE: AVO) has negotiated an additional $200 million in
credit under terms of a new agreement with its senior lender.
The new credit will be available to help finance the
company’s pending acquisition of VISX (NYSE: EYE), according
to a filing last week with the Securities and Exchange
Commission.
The $1.27 billion VISX acquisition, announced in November, is
expected to close during this year’s first quarter, according
to Advanced Medical Optics.
The purchase price includes approximately 29 million shares of
Advanced Medical Optics' stock and $184 million in cash.
January 2005
Latest News
